Public Notice for the 2,195-Ton Annual Production Project of Active Pharmaceutical Ingredients (Phase I) by Wanbangde Pharmaceutical Group Co., Ltd.

Date:

24 Mar,2023

Public Notice Draft for Wanbangde Pharmaceutical Group Co., Ltd.'s Annual Production Project of 2,195 Tons of Active Pharmaceutical Ingredients (Phase I)

The full text is attached.

Good News | Wanbangde Pharmaceutical Group has once again earned two prestigious awards: "Outstanding Chinese Ethnic Medicine Brand Enterprise" and "Top 50 Growing Companies in China's Pharmaceutical Industry"!

Industry-Education Integration and School-Enterprise Collaboration | Wanbangde Pharmaceutical Group Successfully Selected for the "2021–2022 Zhejiang Province Industry-Education Integrated Enterprise" List!

Related Recommendations

2022/10/12

Honors | Wanbangde Group Continues to Rank Among China's Top 500 Private Manufacturing Enterprises in 2022

2022/10/12

United in purpose and rhythm, moving forward with collective strength— A recap of Wanbangde Pharmaceutical Group’s 2022 team-building activities for Quality, Administration, and HR.

2022/10/12

Quality Month | Wanbangde Pharmaceutical Group Successfully Holds 2022 "Quality Month" Kickoff Event

< 1...34 35 36...78 > proceed page

Website Development: China Enterprise Dynamics Taizhou

Business license